Barclays’s Axcelis ACLS Stock Holding History

Barclays’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$341K	Buy	+1,800	New	+$267K	﹤0.01%	3424

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Barclays's ACLS Position: Q2 2026 in Review

Barclays reduced its Axcelis (ACLS) stake by 59% in Q2 2026, selling an estimated $3.09M and leaving 14,532 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

Barclays first reported a position in ACLS in Q2 2013 and has held it in 51 quarters since. The position peaked at $24.3M in Q4 2023. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

Barclays held 14,532 shares of Axcelis worth $2.75M as of Q2 2026.
Barclays sold 20,839 Axcelis shares in Q2 2026, an estimated $3.09M.
Axcelis made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2182 holding.
Barclays first reported a position in Axcelis in Q2 2013 and has held it in 51 quarters since.
Barclays's Axcelis position peaked at $24.3M in Q4 2023.
441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.